Drug Discovery · San Diego, CA · Founded 2017 · Privately Held (backing)
Developer of equitable precision medicines designed to focus on microbial therapeutics for immuno-oncology applications. Persephone Biosciences is based in San Diego, CA and was founded in 2017. It was valued at $37.3 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $21.6 million across 3 recorded rounds; the latest was a $317,000 seed round in Feb 2021.
PMV mark · valuation
$37.3M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$21.6M
Last round
Seed Round
Feb 2021
Cap table — not yet on record
Persephone Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Persephone Biosciences with a free account
·The complete investor list: 31 names
·Watch Persephone Biosciences: the Monday email on marks, rounds and moves
Where does Persephone Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Persephone Biosciences's 3 recorded funding rounds.
